SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expanded partnership with Contexture, a nonprofit, regional health information exchange organization that works to drive health data interoperability. Contexture supports the flow of health information between thousands of physician practices, hospitals, long-term care facilities, labs, radiology ...

Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO & Director Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Stephanie Davis - Barclays Anne Samuel - JPMorgan Jared Haase - William Blair Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity John Ransom - Raymond James Jessica Tassan - Piper Sandler Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Stan Berenshteyn - Wells Far ...

Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 33.33%. A quarter ago, it was expected that this provider of data analytics for the health care industry would post earnings of $0.03 per share when it actually produced earnings of $0.05, delivering a surprise of ...

. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-Q ________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38993 HEALTH CATALYST, INC. (Exact name of registrant as specified in its charte ...

Exhibit 99.1 Key Financial Metrics HealthCatalyst Health Catalyst Reports Second Quarter 2024 Results SALT LAKE CITY, UT, August 7, 2024 — Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024. "For the second quarter of 2024, I am pleased by our strong financial results, including total revenue of $75.9 million and Adjusted EBITDA of $7.5 mill ...

"This financing is an important milestone for Health Catalyst and its shareholders. The Credit Facility not only assists with refinancing our existing convertible notes, but also provides flexibility and additional non-dilutive capital for us to continue to proactively pursue meaningful organic and inorganic growth opportunities, and to continue to act as a consolidation platform for our clients, integrating compelling technologies within our five areas of focus, which we believe positions us well to create ...

Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. A Dana-Farber Cancer Institute study also indicated that telemedicine may considerably cut cancer treatment greenhouse gas emissions. Under these circumstances, telehealth stocks will only gain favor with the investing community. That's why we'll explore three undervalued telehealth stocks, each wit ...

SALT LAKE CITY, June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or ...

SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences: The Stifel Cross Sector Insight Conference, being held in Boston, including a fireside chat on Tuesday, June 4, 2024, at 9:45am ET. T ...

Investors might want to bet on Health Catalyst (HCAT) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. 12 Month EPS Current-Quarter Estimate Revisions The earnings estimate of $0.09 per share for the current quarter represents a change of +80% from the number reported a year ago. The Zacks Consensus Estimate for Health Catalyst has increas ...